Rigel Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57
B.Riley Financial Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $27
Rigel Pharmaceuticals Is Maintained at Neutral by B. Riley Securities
Rigel Pharmaceuticals Price Target Raised to $27.00/Share From $17.00 by B. Riley Securities
Piper Sandler Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $23
Rigel Pharmaceuticals Analyst Ratings
Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $49
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57
Rigel Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57
Rigel Pharmaceuticals Price Target Maintained With a $15.00/Share by Cantor Fitzgerald
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target
Rigel Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57
HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals, Adjusts Price Target To $57 (1-20 Reverse Stock Split)
Rigel Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target
Rigel Pharmaceuticals Analyst Ratings
Rigel Pharmaceuticals Analyst Ratings